PS

Peter Sieling

NA Nantbio: 6 patents #9 of 51Top 20%
IM Immunitybio: 2 patents #18 of 38Top 50%
CU Colorado State University: 1 patents #268 of 752Top 40%
NA Nanocav: 1 patents #7 of 10Top 70%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
UA University Of California Los Angeles: 1 patents #1 of 28Top 4%
Overall (All Time): #531,607 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12350323 Cellular adjuvants for viral infection Kayvan Niazi, Raymond S. Wong, Philip T. Liu 2025-07-08
12329809 Cellular adjuvants for viral infection Kayvan Niazi, Raymond S. Wong, Philip T. Liu 2025-06-17
12290558 SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens Patrick Soon-Shiong, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert, Annie Shin +4 more 2025-05-06
12220452 Cellular adjuvants for viral infection Kayvan Niazi, Raymond S. Wong, Philip T. Liu 2025-02-11
12016883 Primary T-cell expansion Krsto Sbutega, Adam D. Lazar, Kayvan Niazi 2024-06-25
11857620 Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus Patrick Soon-Shiong, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert, Annie Shin +4 more 2024-01-02
11298414 Cellular adjuvants for viral infection Kayvan Niazi, Raymond S. Wong, Philip T. Liu 2022-04-12
10252269 Methods of sorting activated T cells using three dimensional dielectrophoresis Yu-Chun Kung, Ting-Hsiang S. Wu, Kayvan Niazi 2019-04-09
5853737 Method for inducing a CD1-restricted immune response Robert L. Modlin, Michael B. Brenner, Steven A. Porcelli, Patrick Joseph Brennan 1998-12-29